Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-026055
Filing Date
2025-02-25
Accepted
2025-02-25 06:30:22
Documents
62
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nerv-20241231.htm   iXBRL 10-K 2447323
2 EX-19.1 nerv-ex19_1.htm EX-19.1 146248
3 EX-23.1 nerv-ex23_1.htm EX-23.1 3475
4 EX-31.1 nerv-ex31_1.htm EX-31.1 14448
5 EX-31.2 nerv-ex31_2.htm EX-31.2 14145
6 EX-32.1 nerv-ex32_1.htm EX-32.1 10370
  Complete submission text file 0000950170-25-026055.txt   8562298

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nerv-20241231.xsd EX-101.SCH 1118882
65 EXTRACTED XBRL INSTANCE DOCUMENT nerv-20241231_htm.xml XML 1289069
Mailing Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 286 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36517 | Film No.: 25659221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)